drugset
drugset / Trial / NCT01094834

A Multiple Dose Study of DWP05195 in Healthy Adult Subjects

NCT01094834 ↗

Phase 1 Completed 40 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedSingle-groupDouble-blind

Summary

The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of multiple administered DWP05195 in healthy volunteers

Timeline

Start
2010-04
Primary completion
2010-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DWP05195 Small molecule — Oral

Indications

No indication recorded.